John Varigos
John Varigos
Department of Epidemiology and Preventive Medicine, Monash University
Verified email at monash.edu
Title
Cited by
Cited by
Year
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
S Yusuf, S Hawken, S ‘unpuu, T Dans, A Avezum, F Lanas, M McQueen, ...
The lancet 364 (9438), 937-952, 2004
141712004
Cholesterol lowering in intermediate-risk persons without cardiovascular disease
S Yusuf, J Bosch, G Dagenais, J Zhu, D Xavier, L Liu, P Pais, ...
New England Journal of Medicine 374 (21), 2021-2031, 2016
7032016
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo†…
PM Ridker, JG MacFadyen, T Thuren, BM Everett, P Libby, RJ Glynn, ...
The Lancet 390 (10105), 1833-1842, 2017
6372017
Blood-pressure lowering in intermediate-risk persons without cardiovascular disease
EM Lonn, J Bosch, P Lůpez-Jaramillo, J Zhu, L Liu, P Pais, R Diaz, ...
New England Journal of Medicine 374 (21), 2009-2020, 2016
6322016
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ...
The Lancet 391 (10117), 219-229, 2018
5572018
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled†…
PM Ridker, JG MacFadyen, BM Everett, P Libby, T Thuren, RJ Glynn, ...
The Lancet 391 (10118), 319-328, 2018
5112018
Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation
S Yusuf, M Flather, J Pogue, D Hunt, J Varigos, L Piegas, A Avezum, ...
The Lancet 352 (9127), 507-514, 1998
4741998
Blood-pressure and cholesterol lowering in persons without cardiovascular disease
S Yusuf, E Lonn, P Pais, J Bosch, P Lůpez-Jaramillo, J Zhu, D Xavier, ...
New England Journal of Medicine 374 (21), 2032-2043, 2016
3402016
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
SJ Connolly, JW Eikelboom, J Bosch, G Dagenais, L Dyal, F Lanas, ...
The Lancet 391 (10117), 205-218, 2018
2612018
on behalf of the INTERHEART Study Investigators Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case†…
S Yusuf, S Hawken, S ‘unpuu, T Dans, A Avezum, F Lanas, M McQueen, ...
Lancet 364 (9438), 937, 2004
1632004
The system can't perform the operation now. Try again later.
Articles 1–10